Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Return on Investment 2011-2023 | ZTS

Current and historical return on investment (ROI) values for Zoetis (ZTS) over the last 10 years.
  
Zoetis ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2023-12-31 $2.94B $11.56B 25.86%
2023-09-30 $2.88B $11.63B 25.69%
2023-06-30 $2.83B $11.18B 26.27%
2023-03-31 $2.63B $11.05B 25.20%
2022-12-31 $2.66B $10.96B 26.22%
2022-09-30 $2.57B $9.87B 25.26%
2022-06-30 $2.56B $9.80B 24.34%
2022-03-31 $2.53B $9.89B 23.39%
2021-12-31 $2.49B $11.14B 22.60%
2021-09-30 $2.40B $11.27B 22.21%
2021-06-30 $2.34B $10.94B 22.18%
2021-03-31 $2.19B $10.68B 21.11%
2020-12-31 $2.00B $10.37B 20.23%
2020-09-30 $2.01B $10.20B 21.33%
2020-06-30 $1.94B $10.18B 21.20%
2020-03-31 $1.92B $8.72B 21.69%
2019-12-31 $1.80B $8.66B 20.35%
2019-09-30 $1.78B $9.13B 20.15%
2019-06-30 $1.67B $8.86B 19.22%
2019-03-31 $1.65B $8.76B 20.12%
2018-12-31 $1.69B $8.63B 21.77%
2018-09-30 $1.70B $8.56B 23.34%
2018-06-30 $1.70B $6.94B 24.62%
2018-03-31 $1.61B $6.93B 24.59%
2017-12-31 $1.53B $6.74B 24.87%
2017-09-30 $1.33B $6.97B 22.33%
2017-06-30 $1.25B $5.47B 21.81%
2017-03-31 $1.23B $5.35B 21.24%
2016-12-31 $1.23B $5.97B 20.89%
2016-09-30 $1.07B $6.07B 18.45%
2016-06-30 $1.01B $5.84B 18.70%
2016-03-31 $0.65B $5.65B 12.86%
2015-12-31 $0.55B $5.55B 11.46%
2015-09-30 $0.63B $4.48B 13.69%
2015-06-30 $0.60B $4.45B 12.56%
2015-03-31 $0.82B $4.55B 16.91%
2014-12-31 $0.82B $4.96B 16.69%
2014-09-30 $0.79B $5.03B 16.39%
2014-06-30 $0.74B $4.93B 15.72%
2014-03-31 $0.73B $4.74B 15.83%
2013-12-31 $0.69B $4.60B 15.39%
2013-09-30 $0.65B $4.51B 14.45%
2013-06-30 $0.67B $4.46B 20.15%
2013-03-31 $0.74B $4.36B 33.16%
2012-12-31 $0.72B $4.55B 63.12%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $70.026B $8.544B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $53.561B 23.26
Takeda Pharmaceutical (TAK) Japan $41.649B 6.75
Merck (MKGAF) Germany $20.517B 19.36
Astellas Pharma (ALPMY) Japan $17.138B 24.28
Shionogi (SGIOY) Japan $14.066B 12.17
Sandoz Group AG (SDZNY) Switzerland $13.508B 0.00
Neurocrine Biosciences (NBIX) United States $13.189B 54.77
United Therapeutics (UTHR) United States $11.150B 11.94
Catalent (CTLT) United States $10.098B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.652B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.884B 6.98
Ionis Pharmaceuticals (IONS) United States $5.948B 0.00
Revolution Medicines (RVMD) United States $5.901B 0.00
Orion OYJ (ORINY) Finland $5.081B 21.43
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.422B 0.00
Alpine Immune Sciences (ALPN) United States $4.223B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.994B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.801B 0.00
Indivior (INDV) United States $2.587B 12.03
Evotec AG (EVO) Germany $2.534B 0.00
Summit Therapeutics (SMMT) United States $2.463B 0.00
Corcept Therapeutics (CORT) United States $2.346B 23.85
Dyne Therapeutics (DYN) United States $2.038B 0.00
PTC Therapeutics (PTCT) United States $1.891B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.810B 18.71
Fusion Pharmaceuticals (FUSN) Canada $1.803B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.736B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.735B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.646B 9.75
Taro Pharmaceutical Industries (TARO) Israel $1.586B 27.76
Avadel Pharmaceuticals (AVDL) Ireland $1.574B 0.00
Ardelyx (ARDX) United States $1.499B 0.00
4D Molecular Therapeutics (FDMT) United States $1.268B 0.00
Pacira BioSciences (PCRX) United States $1.214B 12.08
Soleno Therapeutics (SLNO) United States $1.206B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.190B 11.18
Xencor (XNCR) United States $1.158B 0.00
Collegium Pharmaceutical (COLL) United States $1.137B 7.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.056B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.928B 0.00
Cronos Group (CRON) Canada $0.921B 0.00
Cassava Sciences (SAVA) United States $0.916B 0.00
Ocular Therapeutix (OCUL) United States $0.871B 0.00
USANA Health Sciences (USNA) United States $0.836B 13.17
Enliven Therapeutics (ELVN) United States $0.827B 0.00
ARS Pharmaceuticals (SPRY) United States $0.814B 0.00
Relay Therapeutics (RLAY) United States $0.802B 0.00
Sage Therapeutics (SAGE) United States $0.783B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.696B 0.00
Savara (SVRA) United States $0.662B 0.00
Silence Therapeutics (SLN) United Kingdom $0.659B 0.00
Lyell Immunopharma (LYEL) United States $0.592B 0.00
Siga Technologies (SIGA) United States $0.585B 8.66
Verve Therapeutics (VERV) United States $0.557B 0.00
ProKidney (PROK) United States $0.550B 0.00
OmniAb (OABI) United States $0.538B 0.00
Korro Bio (KRRO) United States $0.536B 0.00
Exscientia (EXAI) United Kingdom $0.527B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.526B 0.00
Altimmune (ALT) United States $0.488B 0.00
KalVista Pharmaceuticals (KALV) United States $0.485B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.447B 0.00
Heron Therapeutics (HRTX) United States $0.407B 0.00
Larimar Therapeutics (LRMR) United States $0.407B 0.00
Tourmaline Bio (TRML) United States $0.402B 0.00
Lexeo Therapeutics (LXEO) United States $0.398B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.384B 0.00
Harrow (HROW) United States $0.384B 0.00
Organogenesis (ORGO) United States $0.377B 71.50
Bioventus (BVS) United States $0.360B 0.00
Esperion Therapeutics (ESPR) United States $0.354B 0.00
Nature's Sunshine Products (NATR) United States $0.352B 19.68
Aquestive Therapeutics (AQST) United States $0.330B 0.00
Lyra Therapeutics (LYRA) United States $0.322B 0.00
Fractyl Health (GUTS) United States $0.315B 0.00
ESSA Pharma (EPIX) Canada $0.297B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.293B 0.00
Akebia Therapeutics (AKBA) United States $0.291B 0.00
Metagenomi (MGX) United States $0.290B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.280B 0.00
Black Diamond Therapeutics (BDTX) United States $0.274B 0.00
Pyxis Oncology (PYXS) United States $0.263B 0.00
Adherex Technologies (FENC) United States $0.259B 0.00
Nanobiotix S.A (NBTX) France $0.259B 0.00
Xeris Biopharma Holdings (XERS) United States $0.247B 0.00
Nektar Therapeutics (NKTR) United States $0.242B 0.00
Acrivon Therapeutics (ACRV) United States $0.239B 0.00
Telomir Pharmaceuticals (TELO) United States $0.235B 0.00
Foghorn Therapeutics (FHTX) United States $0.235B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Avita Medical (RCEL) United States $0.228B 0.00
Conduit Pharmaceuticals (CDT) United States $0.218B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.209B 0.00
Zevra Therapeutics (ZVRA) United States $0.195B 0.00
Century Therapeutics (IPSC) United States $0.193B 0.00
Profound Medical (PROF) Canada $0.192B 0.00
Prelude Therapeutics (PRLD) United States $0.189B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.184B 0.00
MediWound (MDWD) Israel $0.161B 0.00
Achieve Life Sciences (ACHV) Canada $0.157B 0.00
Incannex Healthcare (IXHL) Australia $0.151B 0.00
CytoDyn (CYDY) United States $0.150B 0.00
Karyopharm Therapeutics (KPTI) United States $0.147B 0.00
VAXART, INC (VXRT) United States $0.146B 0.00
Regulus Therapeutics (RGLS) United States $0.145B 0.00
Elite Pharmaceuticals (ELTP) United States $0.143B 13.35
GlycoMimetics (GLYC) United States $0.139B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.134B 2.83
Relmada Therapeutics (RLMD) United States $0.130B 0.00
Citius Pharmaceuticals (CTXR) United States $0.128B 0.00
Inotiv (NOTV) United States $0.121B 0.00
Eliem Therapeutics (ELYM) United States $0.116B 0.00
FibroGen (FGEN) United States $0.116B 0.00
Cardiol Therapeutics (CRDL) Canada $0.114B 0.00
OptiNose (OPTN) United States $0.105B 0.00
Vivani Medical (VANI) United States $0.099B 0.00
ProPhase Labs (PRPH) United States $0.098B 0.00
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
AlloVir (ALVR) United States $0.085B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.084B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.077B 0.00
Assertio Holdings (ASRT) United States $0.072B 5.80
Journey Medical (DERM) United States $0.071B 0.00
Carisma Therapeutics (CARM) United States $0.071B 0.00
Tempest Therapeutics (TPST) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Mural Oncology (MURA) $0.060B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.059B 0.00
SCYNEXIS (SCYX) United States $0.053B 0.79
BioLineRx (BLRX) Israel $0.051B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Jaguar Animal Health (JAGX) United States $0.049B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
Unicycive Therapeutics (UNCY) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
Viracta Therapeutics (VIRX) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
VYNE Therapeutics (VYNE) United States $0.032B 0.00
JanOne (JAN) United States $0.032B 0.00
Nutriband (NTRB) United States $0.032B 0.00
Protara Therapeutics (TARA) United States $0.031B 0.00
CASI Pharmaceuticals (CASI) China $0.030B 0.00
Lipocine (LPCN) United States $0.029B 0.00
NRx Pharmaceuticals (NRXP) United States $0.029B 0.00
DURECT (DRRX) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 11.00
Oncternal Therapeutics (ONCT) United States $0.023B 0.00
CERo Therapeutics Holdings (CERO) United States $0.023B 0.00
Addex Therapeutics (ADXN) Switzerland $0.022B 0.00
TherapeuticsMD (TXMD) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.022B 1.09
Indaptus Therapeutics (INDP) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
Alaunos Therapeutics (TCRT) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.019B 0.00
Surrozen (SRZN) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.019B 0.00
Talphera (TLPH) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Dominari Holdings (DOMH) United States $0.017B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
Inhibikase Therapeutics (IKT) United States $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.013B 0.00
Biomerica (BMRA) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.010B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.19
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 45.81